Efficacy and safety of Dengzhan Shengmai capsule in the treatment of chronic heart failure: a systematic review and meta-analysis

BackgroundDengzhan Shengmai Capsule (DZSMC) is a potential treatment for chronic heart failure (CHF). However, its specific benefits in the treatment of CHF remain unclear.MethodsRelated randomized controlled trials were searched in eight databases up to January 28, 2025, and included studies were d...

Full description

Saved in:
Bibliographic Details
Main Authors: Shenghua Lu, Yunfeng Yu, Sisi Dai, Yaqi Hu, Qin He, Rongzhen Liu, Jianhe Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2025.1385061/full
Tags: Add Tag
No Tags, Be the first to tag this record!